Cargando…
Acinetobacter Prosthetic Joint Infection Treated with Debridement and High-Dose Tigecycline
Prosthesis retention is not recommended for multidrug-resistant Acinetobacter prosthetic joint infection due to its high failure rate. Nevertheless, replacing the prosthesis implies high morbidity and prolonged hospitalization. Although tigecycline is not approved for the treatment of prosthetic joi...
Autores principales: | Vila, Andrea, Pagella, Hugo, Amadio, Claudio, Leiva, Alejandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204012/ https://www.ncbi.nlm.nih.gov/pubmed/27883369 http://dx.doi.org/10.3947/ic.2016.48.4.324 |
Ejemplares similares
-
Debridement for prosthetic joint infections: future therapies
por: Tsang, S-T. Jerry, et al.
Publicado: (2020) -
Clinical Experience with Tigecycline in the Treatment of Prosthetic Joint Infections
por: Lastinger, Allison, et al.
Publicado: (2017) -
Clinical Experience with Tigecycline in the Treatment of Prosthetic Joint Infections
por: Lastinger, Allison, et al.
Publicado: (2019) -
Chronic Antibiotic Suppression for Nonstaphylococcal Prosthetic Joint Infections Treated with Debridement or Implant Retention
por: Sekar, Poorani, et al.
Publicado: (2021) -
Analysis Of The KLIC-score; An Outcome Predictor Tool For Prosthetic Joint Infections Treated With Debridement, Antibiotics And Implant Retention
por: DX Duffy, Sean, et al.
Publicado: (2018)